EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors

Kayla Bastian, Margarita Orozco-Moreno, Huw Thomas, Kirsty Hodgson, Eline A Visser, Emiel Rossing, Johan F A Pijnenborg, Nienke Eerden, Laura Wilson, Hasvini Saravannan, Oliver Hanley, Grace Grimsley und 17 weitere

Cancer Medicine · 2025

DOI: 10.1002/cam4.70959 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Kayla Bastian und 28 weiteren Autor:innen. Beteiligte Einrichtung: Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK. Hauptthemen laut MEDLINE: Fucosyltransferases, Prostatic Neoplasms, Enzyme Inhibitors. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prostate Cancer UK, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An unmet clinical need requires the discovery of new treatments for men facing advanced prostate cancer. Aberrant glycosylation is a universal feature of cancer cells and plays a key role in tumour growth, immune evasion and metastasis. Alterations in tumour glycosylation are closely associated with prostate cancer progression, making glycans promising therapeutic targets. Fucosyltransferase 8 (FUT8) drives core fucosylation by adding α1,6‐fucose to the innermost GlcNAc residue on N ‐glycans. While FUT8 is recognised as a crucial factor in cancer progression, its role in prostate cancer remains poorly understood. Methods & Results Here, we demonstrate using multiple independent clinical cohorts that FUT8 is upregulated in high grade and metastatic prostate tumours, and in the blood of prostate cancer patients with aggressive disease. Using novel tools, including PhosL lectin immunofluorescence and N ‐glycan MALDI mass spectrometry imaging (MALDI‐MSI), we find FUT8 underpins the biosynthesis of malignant core fucosylated N ‐glycans in prostate cancer cells and using both in vitro and in vivo models, we find FUT8 promotes prostate tumour growth, cell motility and invasion. Mechanistically we show FUT8 regulates the expression of genes and signalling pathways linked to prostate cancer progression. Furthermore, we find that fucosylation inhibitors can inhibit the activity of FUT8 in prostate cancer to suppress the growth of prostate tumours.

Conclusions

Our study cements FUT8‐mediated core fucosylation as an important driver of prostate cancer progression and suggests targeting FUT8 activity for prostate cancer therapy as an exciting area to explore.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FucosyltransferasesProstatic NeoplasmsEnzyme InhibitorsMaleHumansAnimalsMiceGlycosylationCell Line, TumorFucoseCell ProliferationPolysaccharidesCell MovementXenograft Model Antitumor AssaysGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

core fucosylationfucosylation inhibitorsfucosyltransferase 8 (FUT8)glycansprostate cancertherapeuticstumour growth

Substanzen

FucosyltransferasesFucosePolysaccharidesGlycoprotein 6-alpha-L-fucosyltransferaseEnzyme Inhibitors

Autor:innen und Institutionen

  • Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK.
  • Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'gorman Building, Newcastle University, Newcastle upon Tyne, UK.
  • Synthetic Organic Chemistry, Institute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands.
  • GlycoTherapeutics B.V, Nijmegen, the Netherlands.
  • Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Cancer Research Unit, Department of Biology, University of York, North Yorkshire, UK.

ORCID-Profile: Jennifer Munkley

Förderung

  • Prostate Cancer UK
  • Medical Research Council

Zitieren

APA

Bastian, K., Orozco-Moreno, M., Thomas, H., Hodgson, K., Visser, E. A., Rossing, E., Pijnenborg, J. F. A., Eerden, N., Wilson, L., Saravannan, H., Hanley, O., Grimsley, G., Frame, F., Peng, Z., Knight, B., McCullagh, P., McGrath, J., Crundwell, M., Harries, L., …, & Munkley, J. (2025). FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors. Cancer Medicine. https://doi.org/10.1002/cam4.70959

Vancouver

Bastian K, Orozco-Moreno M, Thomas H, Hodgson K, Visser EA, Rossing E, et al. FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors. Cancer Medicine. 2025. doi:10.1002/cam4.70959

BibTeX
@article{Bastian2025,
  author = {Bastian, Kayla and Orozco-Moreno, Margarita and Thomas, Huw and Hodgson, Kirsty and Visser, Eline A and Rossing, Emiel and Pijnenborg, Johan F A and Eerden, Nienke and Wilson, Laura and Saravannan, Hasvini and Hanley, Oliver and Grimsley, Grace and Frame, Fiona and Peng, Ziqian and Knight, Bridget and McCullagh, Paul and McGrath, John and Crundwell, Malcolm and Harries, Lorna and Maitland, Norman J and Heer, Rakesh and Wang, Ning and Goddard-Borger, Ethan D and Guerrero, Ramon Hurtado and Boltje, Thomas J and Drake, Richard R and Scott, Emma and Elliott, David J and Munkley, Jennifer},
  title = {FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70959}
}
Kostenlos starten →